Professor Miles Witham
Dr Claire McDonald
Dr Nina Wilson
Katherine Rennie
Michelle Bardgett
et al. | Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial | 2025 |
|
Dr Morag Andrew
Professor Nicholas Embleton
Professor Janet Berrington
Penny Bradley
Dr Kate Court
et al. | Trial protocol: DOLFIN trial: Developmental Outcomes of Long-term Feed Supplementation in Neonates—A UK multicentre, blinded, stratified, randomised controlled trial | 2025 |
|
Dr Faye Wolstenhulme
Irena Bibby
Mike Cole
Lydia Grixti
Dr Naomi McGregor
et al. | Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease | 2024 |
|
Dr Alaa Abouhajar
Dr Lisa Alcock
Dr Theophile Bigirumurame
Penny Bradley
Laura Brown
et al. | Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy | 2022 |
|
Dr Kate Rennie
Professor Miles Witham
Penny Bradley
Professor Helen Hancock
Shaun Hiu
et al. | MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trial | 2022 |
|
